Brief: Pharming Group Announces Marketing Authorization In U.K. For Joenja® (Leniolisib)

Pharming

26/09/2024 06:09

Sept 26 (Reuters) - Pharming Group NV  PHAR.AS :
    * ANNOUNCES MARKETING AUTHORIZATION IN U.K. FOR JOENJA®
(LENIOLISIB)
    * LENIOLISIB UNDER REGULATORY REVIEW IN EEA, CANADA,
AUSTRALIA
    * LENIOLISIB UNDER NICE EVALUATION FOR NHS REIMBURSEMENT

Source text for Eikon:  ID:nGNE7DY8fh 
Further company coverage:  PHAR.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))